Walleye Trading’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Walleye Trading’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-20,052	Closed	-$263	–	4893
2024 Q3	$263	Hold	20,052	–	–	﹤0.01%	4030
2024 Q2	$844	Hold	20,052	–	–	﹤0.01%	4140
2024 Q1	$1.04K	Hold	20,052	–	–	﹤0.01%	4596
2023 Q4	$1K	Hold	20,052	–	–	﹤0.01%	4914
2023 Q3	$4.41K	Hold	20,052	–	–	﹤0.01%	4644
2023 Q2	$2.61K	Hold	20,052	–	–	﹤0.01%	4455
2023 Q1	$822	Hold	20,052	–	–	﹤0.01%	4729
2022 Q4	$1K	Hold	20,052	–	–	﹤0.01%	4809
2022 Q3	$1K	Hold	20,052	–	–	﹤0.01%	4893
2022 Q2	$2K	Hold	20,052	–	–	﹤0.01%	4949
2022 Q1	$7K	Hold	20,052	–	–	﹤0.01%	5045
2021 Q4	$10K	Buy	+20,052	New	+$11.3K	﹤0.01%	5117

Other funds holding CLDI.WS

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

Walleye Trading's CLDI.WS Position: Q4 2024 in Review

Walleye Trading sold out of Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 (CLDI.WS) in Q4 2024, closing a stake of 20,052 shares — an estimated $263 sold.

Walleye Trading first reported a position in CLDI.WS in Q4 2021 and held it in 12 quarters. The position peaked at $10K in Q4 2021. 1 fund tracked by Wall St. Rank holds CLDI.WS as of Q4 2024.

Walleye Trading reported no remaining Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position as of Q4 2024 after selling out during the quarter.
Walleye Trading sold 20,052 Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 shares in Q4 2024, an estimated $263.
Walleye Trading first reported a position in Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 in Q4 2021 and held it in 12 quarters.
Walleye Trading's Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 position peaked at $10K in Q4 2021.
1 fund tracked by Wall St. Rank held Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 as of Q4 2024.

Based on Walleye Trading's 13F filing for Q4 2024, filed 13 Feb 2025.